Joseph Benesch is CFO at Journey Medical Corp (DERM). They have made 7 open-market trades across 1 company since 2023, most recently 2026-04-22.
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 7 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| DERM | 261,371 | $1.9M |
Shares reported on the most recent Form 4, priced at the 2026-04-24 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| DERM | SELL | 2025-05-02 | 2025-05-05 | $6.84 | $16K | +5.2% | +10.4% | +5.8% |
| DERM | SELL | 2025-02-21 | 2025-02-24 | $5.19 | $7K | -6.3% | +13.7% | +43.9% |
| DERM | SELL | 2024-08-01 | 2024-08-01 | $5.47 | $102K | -11.6% | -12.1% | +5.0% |
| DERM | SELL | 2024-07-23 | 2024-07-23 | $5.40 | $22K | -4.0% | -17.2% | +16.0% |
| DERM | SELL | 2024-02-22 | 2024-02-23 | $3.75 | $9K | -4.4% | -20.0% | -1.4% |
| DERM | SELL | 2023-07-24 | 2023-07-25 | $1.76 | $7K | +20.0% | +17.7% | +85.7% |
| DERM | SELL | 2023-02-22 | 2023-02-23 | $1.97 | $5K | -21.0% | -33.3% | -36.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.